HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven J Gray Selected Research

Aspartylglucosylaminase (Aspartylglucosaminidase)

1/2021Pre-clinical Gene Therapy with AAV9/AGA in Aspartylglucosaminuria Mice Provides Evidence for Clinical Translation.
11/2016Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven J Gray Research Topics

Disease

10Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 03/2015
5GM2 Gangliosidoses (GM2 Gangliosidosis)
01/2022 - 01/2016
5Rett Syndrome (Rett's Disorder)
11/2021 - 01/2013
5Globoid Cell Leukodystrophy (Krabbe Disease)
01/2020 - 04/2015
4Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2022 - 04/2015
4Demyelinating Diseases (Demyelinating Disease)
01/2021 - 08/2010
3Giant Axonal Neuropathy
01/2021 - 02/2013
3Aspartylglucosaminuria
01/2021 - 11/2016
2Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
01/2022 - 01/2021
2Canavan Disease (Leukodystrophy, Spongiform)
01/2021 - 12/2016
2Intellectual Disability (Idiocy)
10/2020 - 01/2007
2Neurodevelopmental Disorders
10/2020 - 10/2017
2Inflammation (Inflammations)
01/2020 - 02/2013
2Sandhoff Disease (Sandhoff's Disease)
03/2019 - 01/2016
2Neuroinflammatory Diseases
01/2018 - 04/2015
1Mental Disorders (Mental Disorder)
01/2022
1Inborn Genetic Diseases (Disease, Hereditary)
01/2022
1Leigh Disease (Leigh's Disease)
12/2021
1Angelman Syndrome (Syndrome, Angelman)
10/2021
1Severe combined immunodeficiency due to adenosine deaminase deficiency
01/2021
1Synucleinopathies
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Atrophy
01/2021
1Color Vision Defects (Color Blindness)
01/2021
1Hemophilia A (Haemophilia)
01/2021
1Hemorrhage
01/2021
1Infections
01/2021
1Macular Degeneration (Age-Related Maculopathy)
01/2021
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2021
1Retinal Diseases
01/2021
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2021
1Tremor (Tremors)
01/2021
1Choroideremia
01/2021
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2021
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2021
1Congenital Structural Myopathies (Centronuclear Myopathy)
01/2021
1Retinoschisis (Retinoschisis, Juvenile)
01/2021
1Leber Congenital Amaurosis
01/2021
1Developmental Disabilities (Developmental Disability)
10/2020
1Autistic Disorder (Autism)
10/2020
1Nervous System Diseases (Neurological Disorders)
01/2020
1Proteostasis Deficiencies
01/2017
1Multiple System Atrophy
01/2017
1Tay-Sachs Disease
01/2016
1Disease Progression
05/2013
1Osteoarthritis
02/2013
1Seizures (Absence Seizure)
01/2010
1Fragile X Syndrome (Martin Bell Syndrome)
01/2007

Drug/Important Bio-Agent (IBA)

11EnzymesIBA
01/2022 - 01/2016
6Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2013
5Hexosaminidase A (Hex A)IBA
01/2022 - 01/2016
4GalactosylceramidaseIBA
01/2020 - 04/2015
3Hexosaminidases (Hexosaminidase)IBA
01/2022 - 01/2016
3Methyl-CpG-Binding Protein 2IBA
10/2020 - 01/2013
2Aspartylglucosylaminase (Aspartylglucosaminidase)IBA
01/2021 - 11/2016
2alpha-SynucleinIBA
01/2021 - 01/2017
2Psychosine (Galactosylsphingosine)IBA
01/2020 - 04/2015
2Pharmaceutical PreparationsIBA
02/2016 - 05/2013
1MicroRNAs (MicroRNA)IBA
11/2021
1ElementsIBA
11/2021
1Protein Isoforms (Isoforms)IBA
10/2021
1Endopeptidase K (Proteinase K)IBA
01/2021
1tisagenlecleucelIBA
01/2021
1axicabtagene ciloleucelIBA
01/2021
1ZolgensmaIBA
01/2021
1Chimeric Antigen ReceptorsIBA
01/2021
1Adenosine DeaminaseIBA
01/2021
1Aromatic-L-Amino-Acid DecarboxylasesIBA
01/2021
1Codon (Codons)IBA
01/2021
1Retinaldehyde (Retinal)IBA
01/2021
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2021
1Carrier Proteins (Binding Protein)IBA
10/2020
1Complementary DNA (cDNA)IBA
03/2019
1Biomarkers (Surrogate Marker)IBA
12/2018
1N-acetylaspartate (N-acetyl aspartate)IBA
12/2016
1Fatty Acids (Saturated Fatty Acids)IBA
12/2016
1aspartoacylaseIBA
12/2016
1Glycoproteins (Glycoprotein)IBA
11/2016
1G(M2) Ganglioside (Ganglioside GM2)IBA
01/2016
1Lysergic Acid Diethylamide (LSD)IBA
04/2015
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2013
1Interleukin-1 (Interleukin 1)IBA
02/2013
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2013
1Ethidium (Ethidium Bromide)IBA
08/2010
1Kainic Acid (Kainate)IBA
01/2010
1Green Fluorescent ProteinsIBA
01/2010
15' Untranslated Regions (5' UTR)IBA
01/2007
1Fragile X Mental Retardation ProteinIBA
01/2007
1AS 8IBA
01/2007

Therapy/Procedure

7Therapeutics
01/2022 - 02/2013
1Precision Medicine
01/2022
1Spinal Injections
01/2020
1Intravenous Injections
01/2018
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2015